一种含有 efavirenz,emtricitabine 和 tenofovir 的固定剂量微乳液的配方和特征
Samantha Mabvira1, Sandile M Khamanga1, Roderick B Walker1
1Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, Makhanda, South Africa.
Pharmaceutical development and technology
|July 24, 2025
概括
一种新的微乳液配方增强了Efavirenz,Emtricitabine和Tenofovir Disoproxil Fumarate的输送,用于HIV管理. 这种固定剂量组合显示出改善抗逆转录病毒疗法的潜力.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 病毒学 病毒学
背景情况:
- 人类免疫缺陷病毒 (HIV) 仍然是一个重大的全球健康挑战,需要有效的抗逆转录病毒疗法.
- 目前的治疗方法可以抑制病毒复制,但不能根除病毒,这凸显了改善药物输送的必要性.
- 固定的剂量组合对于简化艾滋病毒管理和改善患者遵守治疗至关重要.
研究的目的:
- 开发和描述一种新的微乳液 (ME) 配方,用于Efavirenz (EFV),Emtricitabine (FTC) 和Tenofovir Disoproxil Fumarate (TDF) 的固定剂量组合.
- 评估优化的ME配方的物理特征和体外药物释放.
主要方法:
- 使用相位定位制备微乳液,并对药物负载,颗粒大小,透明度,Zeta潜力和pH进行了表征.
- 传输电子显微镜 (TEM) 用于可视化.
- 在体外释放测试中评估了药物释放行为.
- 动态光散射 (DLS),粉末X射线衍射 (PXRD) 和差分扫描热量计 (DSC) 被用于表征.
主要成果:
- 优化的ME配方表现出平均Zeta电位为33.8mV,液滴大小为117nm.
- TEM证实了微乳液结构.
- PXRD和DSC分析表明药物在配方中的分子分散.
- 在体外释放研究表明,该配方的药物释放特征.
结论:
- 开发的微乳液配方提供了一个有前途的固定剂量组合技术,用于提供EFV,FTC和TDF.
- 这种新的方法有可能提高HIV抗逆转录病毒治疗的疗效和方便性.
- 需要进一步的研究来探索这种基于微乳液的药物输送系统的体内性能和治疗益处.
相关概念视频
Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
192
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
192
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
267
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
267
Factors Influencing Drug Absorption: Drug Dissolution
713
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
713


